Advertisement
UK markets open in 4 hours 2 minutes

  • NIKKEI 225

    36,818.81
    -1,260.89 (-3.31%)
     

  • HANG SENG

    16,131.76
    -254.11 (-1.55%)
     

  • CRUDE OIL

    86.10
    +3.37 (+4.07%)
     

  • GOLD FUTURES

    2,420.40
    +22.40 (+0.93%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • Bitcoin GBP

    49,258.33
    -500.95 (-1.01%)
     

  • CMC Crypto 200

    1,244.07
    +358.53 (+37.63%)
     

  • NASDAQ Composite

    15,601.50
    -81.87 (-0.52%)
     

  • UK FTSE All Share

    4,290.02
    +17.00 (+0.40%)
     
Money:

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

Contract Small Molecule API Manufacturing Industry by the Numbers - 2021 Edition

ReportLinker
·1-min read

Summary This report is an updated version of the 2019 edition and characterizes the contract small molecule active pharmaceutical ingredient (API) manufacturing industry through a number of quantitative dimensions, including number and type of participants, containment and controlled substance capabilities, and financial performance of the top public contract manufacturing organizations (CMOs).

New York, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Contract Small Molecule API Manufacturing Industry by the Numbers - 2021 Edition" - https://www.reportlinker.com/p06197284/?utm_source=GNW
Contract Small Molecule API Manufacturing is critical for establishing an understanding of the small molecule API CMO industry and the features of some of the largest CMOs participating in the industry.

Scope
- This 53-page report gives important, expert insight you won’t find in any other source. 31 tables and figures throughout the report illustrate major points and trends. This report is required reading for:
- CMO executives who must have deep understanding of the small molecule API marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy
- Overview of contract small molecule API facilities and the proportion of containment and controlled substance specialist capabilities
- Detailed view of the geographic distribution of small molecule API facilities
- Establishing which CMOs are most involved in contract small molecule API industry by facility count
- Analysis of M&A activity related to small molecule API facilities
Read the full report: https://www.reportlinker.com/p06197284/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001